Cargando…

HDAC1 and HDAC2 Regulate Oligodendrocyte Differentiation By Disrupting β-Catenin-TCF Interaction

Oligodendrocyte development is regulated by the interplay of repressors and activators in a complex transcriptional network. Here we report that two histone-modifying enzymes, HDAC1 and HDAC2, are required for oligodendrocyte formation. Genetic deletion of both HDAC1 and HDAC2 in oligodendrocyte lin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Feng, Chen, Ying, Hoang, ThaoNguyen, Montgomery, Rusty L., Zhao, Xian-hui, Bu, Hong, Hu, Tom, Taketo, Makoto M., van Es, Johan H., Clevers, Hans, Hsieh, Jenny, Bassel-Duby, Rhonda, Olson, Eric N., Lu, Q. Richard
Formato:	Texto
Lenguaje:	English
Publicado:	2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701973/ https://www.ncbi.nlm.nih.gov/pubmed/19503085 http://dx.doi.org/10.1038/nn.2333

Ejemplares similares

Specific Control of Pancreatic Endocrine β- and δ-Cell Mass by Class IIa Histone Deacetylases HDAC4, HDAC5, and HDAC9
por: Lenoir, Olivia, et al.
Publicado: (2011)

Class I HDAC Inhibition Blocks Cocaine-Induced Plasticity Through Targeted Changes in Histone Methylation
por: Kennedy, Pamela J., et al.
Publicado: (2013)

Tcf7l2/Tcf4 Transcriptional Repressor Function Requires HDAC Activity in the Developing Vertebrate CNS
por: Wang, Hui, et al.
Publicado: (2016)

Expression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in Invasive Ductal Carcinomas of the Breast
por: Seo, Jinwon, et al.
Publicado: (2014)

Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma
por: Huang, Renhong, et al.
Publicado: (2018)

HDAC1 Regulates Neuronal Differentiation
por: Nieto-Estevez, Vanesa, et al.
Publicado: (2022)

Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
por: Thomas, Elizabeth A.
Publicado: (2014)

HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases
por: Yoon, Somy, et al.
Publicado: (2016)

HDAC1 promoted migration and invasion binding with TCF12 by promoting EMT progress in gallbladder cancer
por: He, Junyi, et al.
Publicado: (2016)

Selective HDAC Inhibition for the Disruption of Latent HIV-1 Infection
por: Barton, Kirston M., et al.
Publicado: (2014)

Combined PDGFR and HDAC Inhibition Overcomes PTEN Disruption in Chordoma
por: Lee, Dae-Hee, et al.
Publicado: (2015)

HDAC3 and HDAC8 are required for cilia assembly and elongation
por: Park, Seon-ah, et al.
Publicado: (2019)

Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
por: King, Jacob, et al.
Publicado: (2021)

HDAC1 and HDAC2 Double Knockout Triggers Cell Apoptosis in Advanced Thyroid Cancer
por: Lin, Ching-Ling, et al.
Publicado: (2019)

HDAC-inhibitor (S)-8 disrupts HDAC6-PP1 complex prompting A375 melanoma cell growth arrest and apoptosis
por: Balliu, Manjola, et al.
Publicado: (2015)

Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines
por: Sixto-López, Yudibeth, et al.
Publicado: (2020)

Continuous Activity Assay for HDAC11 Enabling Reevaluation of HDAC Inhibitors
por: Kutil, Zsófia, et al.
Publicado: (2019)

HDAC Inhibitors Disrupt Programmed Resistance to Apoptosis During Drosophila Development
por: Kang, Yunsik, et al.
Publicado: (2017)

The HDAC interaction network
por: Livyatan, Ilana, et al.
Publicado: (2013)

Tcf1 and Lef1 transcription factors establish CD8(+) T cell identity through intrinsic HDAC activity
por: Xing, Shaojun, et al.
Publicado: (2016)

Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis
por: Winter, Mircea, et al.
Publicado: (2013)

Both HDAC5 and HDAC6 are required for the proliferation and metastasis of melanoma cells
por: Liu, Jiaqi, et al.
Publicado: (2016)

Distinct requirements for Tcf3 and Tcf12 during oligodendrocyte development in the mouse telencephalon
por: Talley, Mary Jo, et al.
Publicado: (2023)

H3K9ac and HDAC2 Activity Are Involved in the Expression of Monocarboxylate Transporter 1 in Oligodendrocyte
por: Lai, Qingwei, et al.
Publicado: (2017)

Comprehensive Analysis of HDAC Family Identifies HDAC1 as a Prognostic and Immune Infiltration Indicator and HDAC1-Related Signature for Prognosis in Glioma
por: Fan, Yuxiang, et al.
Publicado: (2021)

Regulating the Regulators: The Post-Translational Code of Class I HDAC1 and HDAC2
por: Segré, Chiara V., et al.
Publicado: (2011)

HDAC1 and HDAC6 are essential for driving growth in IDH1 mutant glioma
por: Garrett, Matthew C., et al.
Publicado: (2023)

Understanding Failure and Improving Treatment Using HDAC Inhibitors for Prostate Cancer
por: Rana, Zohaib, et al.
Publicado: (2020)

HDAC9 structural variants disrupting TWIST1 transcriptional regulation lead to craniofacial and limb malformations
por: Hirsch, Naama, et al.
Publicado: (2022)

Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma
por: Noll, Alyssa, et al.
Publicado: (2023)

The Role of HDAC6 in Cancer
por: Aldana-Masangkay, Grace I., et al.
Publicado: (2011)

HDAC6 and Ovarian Cancer
por: Haakenson, Joshua, et al.
Publicado: (2013)

Class IIa HDACs in myelination
por: Velasco-Aviles, Sergio, et al.
Publicado: (2018)

Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma
por: Que, Yi, et al.
Publicado: (2021)

HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?
por: Simões-Pires, Claudia, et al.
Publicado: (2013)

CD4(+) T cell lineage integrity is controlled by the histone deacetylases HDAC1 and HDAC2
por: Boucheron, Nicole, et al.
Publicado: (2014)

HDAC1 and HDAC2 Modulate TGF-β Signaling during Endothelial-to-Hematopoietic Transition
por: Thambyrajah, Roshana, et al.
Publicado: (2018)

HDAC1 and HDAC2 independently regulate common and specific intrinsic responses in murine enteroids
por: Gonneaud, Alexis, et al.
Publicado: (2019)

Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitors
por: Galán, María, et al.
Publicado: (2016)

HDAC6 regulates IL-17 expression in T lymphocytes: implications for HDAC6-targeted therapies
por: Yan, Bing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9hj191onshffr22qhgd4q5l5e2